Safety and immunogenicity of influenza whole inactivated virus vaccines: A phase I randomized clinical trial

BACKGROUND: Influenza vaccine production capacity is still insufficient to meet global demand in case of a pandemic. To expand worldwide influenza vaccine production capacity, a solid and transferable egg-based influenza vaccine production process was established that is suitable for upscaling and t...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Hum Vaccin Immunother
Auteurs principaux: van Boxtel, Renée A J, Verdijk, Pauline, de Boer, Otto J, van Riet, Elly, Mensinga, Tjeert T, Luytjes, Willem
Format: Artigo
Langue:Inglês
Publié: Taylor & Francis 2015
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4514258/
https://ncbi.nlm.nih.gov/pubmed/25751506
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2015.1012004
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires